investigations using 3h-arteparon ( 3h-glycosaminoglycan polysulfate , 3h-gagps ) showed that in humans with degenerative joint disease an intramuscular administration of 125 mg gagps ( 0.5 ml arteparon forte ) produces gagps concentrations within the joint , which in a biochemical assay inhibit cartilage degrading lysosomal enzymes .
C0029408
degenerative joint disease
C0022417
joint